Space Travel News  
INTERN DAILY
China mulls $720,000 fine for faking vaccine tests after scandal
by Staff Writers
Beijing (AFP) Nov 12, 2018

Chinese vaccine manufacturers who falsify test results or break other rules could be fined up to $720,000 under a new law proposed after a scandal that fulled public fears over domestically made medicine.

The law would regulate areas including production, distribution and use of vaccines, according to a draft posted Sunday on the website of China's market regulator.

The country was earlier this year rocked by a scandal that saw a manufacturer of rabies vaccines fabricating records.

While authorities say the affected vaccines did not enter the market, the case provoked outrage from consumers fed up with recurring product safety scandals, particularly in pharmaceuticals.

Under the proposed law, those who flout the rules can be fined up to 5.0 million yuan ($720,000) for offences including submitting false test results, not recalling problematic batches and "other serious illegal acts".

"Those who participate in illegal behaviour, shield or connive with violators, hide the facts through fabrication, or impede investigation will receive severe punishment," the draft said.

This is the first time a law has explicitly targeted vaccines, which were previously covered by regulations controlling medicine.

The authorities last month slapped the Changchun Changsheng Biotechnology company with a massive $1.3 billion in penalties over the rabies vaccine scandal.

The firm's chairwoman and 14 other people were arrested in connection with the affair in July while more than a dozen national, provincial and local officials were sacked, including several senior officials from the drug regulatory agency.

China is regularly hit by scandals involving sub-par or toxic food, drugs and other products, despite repeated promises by the government to address the problem.

After the latest case came to light, the authorities announced a nationwide inspection of laboratories producing vaccines.

But many Chinese parents say they no longer have confidence in the medicines administered to their children.

During the height of the scandal, clinics in Hong Kong saw a run on their vaccine stocks by worried parents from the mainland.

President Xi Jinping described the vaccine debacle as "vile" and "shocking" in July while Premier Li Keqiang said the latest case had crossed a "line of human ethics".

In August, India ordered a recall of rabies vaccines made by Changchun Changsheng and complained that it only found out about possible problems through media reports.


Related Links
Hospital and Medical News at InternDaily.com


Thanks for being here;
We need your help. The SpaceDaily news network continues to grow but revenues have never been harder to maintain.

With the rise of Ad Blockers, and Facebook - our traditional revenue sources via quality network advertising continues to decline. And unlike so many other news sites, we don't have a paywall - with those annoying usernames and passwords.

Our news coverage takes time and effort to publish 365 days a year.

If you find our news sites informative and useful then please consider becoming a regular supporter or for now make a one off contribution.
SpaceDaily Contributor
$5 Billed Once


credit card or paypal
SpaceDaily Monthly Supporter
$5 Billed Monthly


paypal only


INTERN DAILY
Use of monkeys for medical research hits all-time high
Washington (UPI) Nov 5, 2018
Use of monkeys in medical research hit an all-time high in 2017, according to United States Department of Agriculture data. Last year, scientists used close to 76,000 primates for research, up by 22 percent from 2015 and 6 percent in 2008, according to a USDA report. Experts think primates are better animals for testing of drugs and study of diseases than mice or dogs because of their genetic and physical similarity to humans. "I think the numbers are trending up because these animals gi ... read more

Comment using your Disqus, Facebook, Google or Twitter login.



Share this article via these popular social media networks
del.icio.usdel.icio.us DiggDigg RedditReddit GoogleGoogle

INTERN DAILY
INTERN DAILY
The Mars InSight Landing Site Is Just Plain Perfect

Evidence of outburst flooding indicates plentiful water on early Mars

Water cycle along the northern rim of Hellas Basin throughout Mars' history

Five things to know about InSight's Mars landing

INTERN DAILY
European-built Service Module arrives in US for first Orion lunar mission

Roscosmos to Study Possibility to 3D Print Lunar Soil Details for Space Repairs

First moon walk's commemorative plaque sold for $468,500

Neil Armstrong's huge souvenir collection to be auctioned

INTERN DAILY
SwRI team makes breakthroughs studying Pluto orbiter mission

ALMA maps temperature of Jupiter's icy moon Europa

NASA's Juno Mission Detects Jupiter Wave Trains

WorldWide Telescope looks ahead to New Horizons' Ultima Thule glyby

INTERN DAILY
Laser tech could be fashioned into Earth's 'porch light' to attract alien astronomers

Laboratory experiments probe the formation of stars and planets

NASA retires Kepler Space Telescope, passes planet-hunting torch

Rocky and habitable - sizing up a galaxy of planets

INTERN DAILY
Russia plans to carry out 17 space launches in 2018

Simulating hypersonic flow transitions from smooth to turbulent

Fregat Upper Stage Separates From Soyuz Carrier Bringing Satellite to Orbit

Hole in Soyuz MS-09 hull could have been drilled before launch

INTERN DAILY
China's space programs open up to world

China's commercial aerospace companies flourishing

China launches Centispace-1-s1 satellite

China tests propulsion system of space station's lab capsules

INTERN DAILY
New insights on comet tails are blowing in the solar wind

NASA'S OSIRIS-REx zooms in on Bennu

Dawn Mission to Asteroid Belt comes to end

NASA's Dawn asteroid mission ends as fuel runs out









The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us.